How to Subdue Stubborn Acne for Good

An upcoming exclusive discussion explores how to subdue patients most stubborn acne for good, giving patients long-term relief in the war against acne.
An upcoming exclusive discussion explores how to subdue patients most stubborn acne for good, giving patients long-term relief in the war against acne.
Image by Drobot Dean at Adobe Stock

ūüĎČūüŹĹRegistration is now open for our free webcast,¬†Evaluating the Long-Term Efficacy of AviClear¬†(Tuesday, July 09, 2024 at¬†2:00 PM Central U.S. Time)¬†

DelveInsight's Acne Vulgaris Market Insights report projects the market to grow significantly by 2034. The growing awareness about skin care and beauty standards fuels the demand for advanced therapeutic solutions, and emerging therapies with improved efficacy and a further improvement in the diagnosis rate further drives the growth of the acne vulgaris market. 

Stubborn acne requires a durable solution to treat active, inflammatory acne and prevent future breakouts. In our upcoming webcast exclusive, Evaluating the Long-Term Efficacy of AviClear, Emmy M. Graber, M.D., M.B.A., will dive into the long-term efficacy of AviClear, the first and original 1726nm energy-based acne treatment to receive long-term clearance from the FDA. 

Dr. Graber will discuss the recent clinical studies exploring the long-term efficacy of AviClear for the treatment of acne, review treatment best practices and how to integrate AviClear into your aesthetic practice, while taking into account considerations such as patient demographics as well as the current acne market. 

This session is a must-attend for any aesthetics provider (Dermatologist, MedSpa Owner, MD/DO, Aesthetics Practitioner, Medical Practice Owner, etc.) looking to provide your patients with a long-term solution to stubborn acne. 

Join us live or on-demand for: 

  • How AviClear works: The 1726 nm wavelength
  • The Long-Term Efficacy of AviClear: Clinical Studies and Results
  • Integrating AviClear Into Your Practice: Patient Demographics and The Current Acne Market

About our speaker:

Emmy M. Graber, M.D., M.B.A. is the Founder of The Dermatology Institute of Boston, a private practice in Boston, Massachusetts. With over ten years experience, Dr. Graber, a board-certified dermatologist, treats a wide range of dermatologic issues and specializes inacneand cosmetic dermatology. She is currently an Affiliate Clinical Instructor at Northeastern University and has extensive experience teaching students of all types.

ūüĎČūüŹĹRegister now for live or on demand access.

More in Treatments